Make your money go further for just 25p per day

PREMIUM
AIM IHT

Benefit from the boom in healthcare Artificial Intelligence (Updated)

AI imagery

This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over recent years and, following recent share price falls, now looks cracking value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years. The order book, while down on the prior year, still offers plenty of visibility and this fascinating business is certainly worth a close look. (IHT qualifying)


IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.


Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.

The Group is a…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on IXICO PLC

A move to Bonkers Bargain

08/12/2021 · Company Insights

One small company covered here is leading the way in delivering insights in neuroscience, yet the…


Benefit from the boom in healthcare Artificial Intelligence (Updated)

07/12/2021 · Company Insights

This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over…


More Company Insights

AIM Innovators: Creo Medical initiates partnership strategy

AIM Innovators: A future-proof portfolio for stock pickers

21/01/2022

Marlowe: fudging the numbers?

20/01/2022 · Marlowe PLC · Restore PLC

Sign-up to our free email updates

SIGN UP